Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.286, 2000-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Imatinib still cost effective for CML
Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. :
Access to resources
Recommend
Losartan a "cost-effective intervention" for hypertension
Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. :
Dutasteride "cost-effective" for BPH in Poland
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 517, 2006-01 ,pp. :
Searching for cost-effective options in Italy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :
Ramipril `highly cost-effective' in Sweden
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :